The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Hill-Rom Holdings Inc

NYSE: HRC
Last

(U.S.) $43.90

Today's change-2.03 -4.42%
Updated February 8 4:02 PM EST. Delayed by at least 15 minutes.
 

Hill-Rom Holdings Inc

NYSE: HRC
Last

(U.S.) $43.90

Today's change-2.03 -4.42%
Updated February 8 4:02 PM EST. Delayed by at least 15 minutes.

Hill-Rom Holdings Inc down (U.S.)$2.03

Hill-Rom Holdings Inc closed sharply lower Monday, dropping (U.S.)$2.03 or 4.42% to (U.S.)$43.90. Over the last five days, shares have lost 10.95% and sit 1.04% above their 52-week low. This security has outperformed the S&P 500 by 3.69% during the last year.

Key company metrics

  • Open(U.S.) $45.44
  • Previous close(U.S.) $45.93
  • High(U.S.) $45.44
  • Low(U.S.) $43.45
  • Bid / Ask(U.S.) $40.17 / (U.S.) $47.67
  • YTD % change-8.66%
  • Volume812,946
  • Average volume (10-day)635,033
  • Average volume (1-month)687,383
  • Average volume (3-month)541,470
  • 52-week range(U.S.) $43.45 to (U.S.) $58.73
  • Beta1.28
  • Trailing P/E63.13×
  • P/E 1 year forward14.03×
  • Forward PEG0.86×
  • Indicated annual dividend(U.S.) $0.64
  • Dividend yield1.46%
  • Trailing EPS(U.S.) $0.70
Updated February 8 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+1.79%

Based on its net profit margin of 1.79%, Hill-Rom Holdings Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.79%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue661574475475
Total other revenue--------
Total revenue661574475475
Gross profit291257210214
Total cost of revenue371317265261
Total operating expense632580443437
Selling / general / administrative221209151150
Research & development34252322
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)72944
Other operating expenses, total--------
Operating income29-63138
Interest income (expense), net non-operating-23-9-3-3
Gain (loss) on sale of assets--------
Other--------
Income before tax6-172837
Income after tax4-101926
Income tax, total2-6911
Net income5-91926
Total adjustments to net income--------
Net income before extra. items5-91926
Minority interest11----
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items5-91926
Inc. avail. to common incl. extra. items5-91926
Diluted net income5-91926
Dilution adjustment----0--
Diluted weighted average shares66585858
Diluted EPS excluding extraordinary itemsvalue per share0.07-0.160.330.45
Dividends per sharevalue per share0.160.160.160.16
Diluted normalized EPSvalue per share-0.55-0.67-0.010.13